Editorial
Published on 20 Feb 2023
Editorial: Biology and treatment of high-risk CLL
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1109950
- 1,572 views
Type at least 3 characters
1,688 articles
Articles
Original Research
Published on 17 Feb 2023
Multicolor flow cytometric assessment of Ki67 expression and its diagnostic value in mature B-cell neoplasms
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1108837
- 3,637 views
- 1 citation
Case Report
Published on 17 Feb 2023
Case report: Genomic analysis of a therapy-related chronic myelomonocytic leukemia with KMT2A rearrangement that progressed to acute myeloid leukemia with acute promyelocytic leukemia-like features
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1116418
- 2,343 views
Systematic Review
Published on 16 Feb 2023
Post-transplant cyclophosphamide versus anti-thymocyte globulin in allogeneic hematopoietic stem cell transplantation from unrelated donors: A systematic review and meta-analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1071268
- 2,964 views
- 6 citations
Original Research
Published on 16 Feb 2023
Characterization of clonal immunoglobulin heavy V-D-J gene rearrangements in Chinese patients with chronic lymphocytic leukemia: Clinical features and molecular profiles
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1120867
- 1,753 views
- 2 citations
Original Research
Published on 16 Feb 2023
Unmanipulated haploidentical hematopoietic stem cell transplantation for pediatric de novo acute megakaryoblastic leukemia without Down syndrome in China: A single-center study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1116205
- 2,001 views
- 3 citations
Original Research
Published on 15 Feb 2023
A diagnostic scoring model of ENKTCL in the nose-Waldeyer’s ring based on logistic regression: Differential diagnosis from DLBCL
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1065440
- 1,331 views
Original Research
Published on 15 Feb 2023
Lamivudine 24-month-long prophylaxis is a safe and efficient choice for the prevention of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients with advanced DLBCL undergoing upfront R-CHOP-21
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1130899
- 1,827 views
- 2 citations
Correction
Published on 14 Feb 2023
Corrigendum: Poly(rC)-binding proteins as pleiotropic regulators in hematopoiesis and hematological malignancy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2022.1132485
- 782 views
Review
Published on 14 Feb 2023
Measurable residual disease in chronic lymphocytic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1112616
- 6,520 views
- 2 citations
Editorial
Published on 14 Feb 2023
Editorial: Epidemiological trends in hematological malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1151774
- 1,425 views
Original Research
Published on 14 Feb 2023
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1117815
- 2,666 views
- 7 citations
Original Research
Published on 10 Feb 2023
In-depth circulating tumor DNA sequencing for prognostication and monitoring in natural killer/T-cell lymphomas
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1109715
- 2,501 views
- 6 citations
Original Research
Published on 10 Feb 2023
A novel ferroptosis-related gene signature for predicting prognosis in multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.999688
- 3,938 views
- 4 citations
Opinion
Published on 09 Feb 2023
Opinion: What defines high-risk CLL in the post-chemoimmunotherapy era?
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1106579
- 4,499 views
- 1 citation
Original Research
Published on 09 Feb 2023
Mitochondrial gene expression signature predicts prognosis of pediatric acute myeloid leukemia patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1109518
- 2,975 views
- 3 citations